Omega-3 Fatty Acids Eicosapentaenoic Acid and Docosahexaenoic Acid in the Management of Hypercalciuric Stone Formers

ObjectiveTo investigate the use of fish oil in the dietary management of hypercalciuric stone formers. Prostaglandins have been linked to urinary calcium excretion, suggesting a role for omega-3 fatty acids in the treatment of hypercalciuric urolithiasis.MethodsWe retrospectively studied a cohort of patients treated at our stone clinics from July 2007 to February 2009. Patients' urinary risk factors for stone disease were evaluated with pre- and post-intervention 24-hour urine collections. All patients received empiric dietary recommendations for intake of fluids, sodium, protein, and citric juices. All subjects with hypercalciuria (urinary calcium >250 mg/d for males or >200 mg/d for females) on at least two 24-hour urine collections were counseled to supplement their diet with fish oil (1200 mg/d).ResultsTwenty-nine patients were followed for 9.86 ± 8.96 months. The mean age was 43.38 ± 13.78 years. Urinary calcium levels decreased in 52% of patients, with 24% converting to normocalciuria. The average urinary calcium (mg/d) decreased significantly from baseline (329.27 ± 96.23 to 247.47 ± 84.53, P <.0001). Urinary oxalate excretion decreased in 34% of patients. The average urinary oxalate (mg/d) decreased significantly from baseline (45.40 ± 9.90 to 32.9 ± 8.21, P = .0004). Urinary citrate (mg/d) increased in 62% of subjects from baseline (731.67 ± 279.09 to 940.22 ± 437.54, P = .0005). Calcium oxalate supersaturation decreased in 38% of the subjects significantly from baseline (9.73 ± 4.48 to 3.68 ± 1.76, P = .001).ConclusionOmega-3 fatty acids combined with empiric dietary counseling results in a measurable decrease in urinary calcium and oxalate excretion and an increase in urinary citrate in hypercalciuric stone formers.